Original Research

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhang Z, Ni L, Zhang L, Zha D, Hu C, Zhang L, Feng H, Wei X, Wu X

Diabetes, Metabolic Syndrome and Obesity 2021, 14:227-240

Published Date: 18 January 2021